APO RESEARCH · REPORT
Pharmacy Benefit Management (PBM)
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
Product & engineering
Understand the product.
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.
Selected research
Market Analysis & Forecast
Global Pharmacy Benefit Management (PBM) Market Analysis and Forecast 2026-2032
Market perspective
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.
Three major PBMs maufacturters include Express Scripts, CVS Health, and OptumRx of UnitedHealth Group, which comprise 75% of the market.
Read the full market overview
USA region is enjoying the largest market share of Pharmacy Benefit Management (PBM), with a market share nearly 97%. EU is the second place of Pharmacy Benefit Management (PBM), enjoying market share nearly 2%.
Report Includes
This report presents an overview of global market for Pharmacy Benefit Management (PBM), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharmacy Benefit Management (PBM), also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmacy Benefit Management (PBM), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmacy Benefit Management (PBM) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmacy Benefit Management (PBM) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmacy Benefit Management (PBM) revenue, projected growth trends, production technology, application and end-user industry.
Pharmacy Benefit Management (PBM) Segment by Company
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet
Pharmacy Benefit Management (PBM) Segment by Type
Commercial Health Plans
Self-insured Employer Plans
Medicare Part D plans
Federal Employees Health Benefits Program
State Government Employee Plans
Pharmacy Benefit Management (PBM) Segment by Application
Mail-order Pharmacy Services
Non-mail Pharmacy Services
Pharmacy Benefit Management (PBM) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacy Benefit Management (PBM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacy Benefit Management (PBM) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacy Benefit Management (PBM).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmacy Benefit Management (PBM) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmacy Benefit Management (PBM) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacy Benefit Management (PBM) revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Commercial Health Plans
- Self-insured Employer Plans
- Medicare Part D plans
- Federal Employees Health Benefits Program
- State Government Employee Plans
Applications
- Mail-order Pharmacy Services
- Non-mail Pharmacy Services
Companies covered
- CVS Health (CVS)
- Express Scripts
- OptumRx (UnitedHealth)
- Humana Pharmacy Solutions
- Prime Therapeutics
- Medimpact Healthcare
- Magellan Health
- BC/BS
- Vidalink
- Sea Rainbow
- Cachet
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharmacy Benefit Management (PBM) Market by Type
- 1.2.1 Global Pharmacy Benefit Management (PBM) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Commercial Health Plans
- 1.2.3 Self-insured Employer Plans
- 1.2.4 Medicare Part D plans
- 1.2.5 Federal Employees Health Benefits Program
- 1.2.6 State Government Employee Plans
- 1.3 Pharmacy Benefit Management (PBM) Market by Application
- 1.3.1 Global Pharmacy Benefit Management (PBM) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Mail-order Pharmacy Services
- 1.3.3 Non-mail Pharmacy Services
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmacy Benefit Management (PBM) Market Dynamics
- 2.1 Pharmacy Benefit Management (PBM) Industry Trends
- 2.2 Pharmacy Benefit Management (PBM) Industry Drivers
- 2.3 Pharmacy Benefit Management (PBM) Industry Opportunities and Challenges
- 2.4 Pharmacy Benefit Management (PBM) Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pharmacy Benefit Management (PBM) Market Perspective (2021-2032)
- 3.2 Global Pharmacy Benefit Management (PBM) Growth Trends by Region
- 3.2.1 Global Pharmacy Benefit Management (PBM) Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharmacy Benefit Management (PBM) Market Size by Region (2021-2026)
- 3.2.3 Global Pharmacy Benefit Management (PBM) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pharmacy Benefit Management (PBM) Revenue by Players
- 4.1.1 Global Pharmacy Benefit Management (PBM) Revenue by Players (2021-2026)
- 4.1.2 Global Pharmacy Benefit Management (PBM) Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pharmacy Benefit Management (PBM) Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharmacy Benefit Management (PBM) Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pharmacy Benefit Management (PBM) Key Players Headquarters & Area Served
- 4.4 Global Pharmacy Benefit Management (PBM) Players, Product Type & Application
- 4.5 Global Pharmacy Benefit Management (PBM) Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pharmacy Benefit Management (PBM) Market CR5 and HHI
- 4.6.3 2025 Pharmacy Benefit Management (PBM) Tier 1, Tier 2, and Tier 3
5 Pharmacy Benefit Management (PBM) Market Size by Type
- 5.1 Global Pharmacy Benefit Management (PBM) Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 5.3 Global Pharmacy Benefit Management (PBM) Revenue Market Share by Type (2021-2032)
6 Pharmacy Benefit Management (PBM) Market Size by Application
- 6.1 Global Pharmacy Benefit Management (PBM) Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 6.3 Global Pharmacy Benefit Management (PBM) Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 CVS Health (CVS)
- 7.1.1 CVS Health (CVS) Company Information
- 7.1.2 CVS Health (CVS) Business Overview
- 7.1.3 CVS Health (CVS) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.1.4 CVS Health (CVS) Pharmacy Benefit Management (PBM) Product Portfolio
- 7.1.5 CVS Health (CVS) Recent Developments
- 7.2 Express Scripts
- 7.2.1 Express Scripts Company Information
- 7.2.2 Express Scripts Business Overview
- 7.2.3 Express Scripts Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.2.4 Express Scripts Pharmacy Benefit Management (PBM) Product Portfolio
- 7.2.5 Express Scripts Recent Developments
- 7.3 OptumRx (UnitedHealth)
- 7.3.1 OptumRx (UnitedHealth) Company Information
- 7.3.2 OptumRx (UnitedHealth) Business Overview
- 7.3.3 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.3.4 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Product Portfolio
- 7.3.5 OptumRx (UnitedHealth) Recent Developments
- 7.4 Humana Pharmacy Solutions
- 7.4.1 Humana Pharmacy Solutions Company Information
- 7.4.2 Humana Pharmacy Solutions Business Overview
- 7.4.3 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.4.4 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Product Portfolio
- 7.4.5 Humana Pharmacy Solutions Recent Developments
- 7.5 Prime Therapeutics
- 7.5.1 Prime Therapeutics Company Information
- 7.5.2 Prime Therapeutics Business Overview
- 7.5.3 Prime Therapeutics Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.5.4 Prime Therapeutics Pharmacy Benefit Management (PBM) Product Portfolio
- 7.5.5 Prime Therapeutics Recent Developments
- 7.6 Medimpact Healthcare
- 7.6.1 Medimpact Healthcare Company Information
- 7.6.2 Medimpact Healthcare Business Overview
- 7.6.3 Medimpact Healthcare Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.6.4 Medimpact Healthcare Pharmacy Benefit Management (PBM) Product Portfolio
- 7.6.5 Medimpact Healthcare Recent Developments
- 7.7 Magellan Health
- 7.7.1 Magellan Health Company Information
- 7.7.2 Magellan Health Business Overview
- 7.7.3 Magellan Health Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.7.4 Magellan Health Pharmacy Benefit Management (PBM) Product Portfolio
- 7.7.5 Magellan Health Recent Developments
- 7.8 BC/BS
- 7.8.1 BC/BS Company Information
- 7.8.2 BC/BS Business Overview
- 7.8.3 BC/BS Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.8.4 BC/BS Pharmacy Benefit Management (PBM) Product Portfolio
- 7.8.5 BC/BS Recent Developments
- 7.9 Vidalink
- 7.9.1 Vidalink Company Information
- 7.9.2 Vidalink Business Overview
- 7.9.3 Vidalink Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.9.4 Vidalink Pharmacy Benefit Management (PBM) Product Portfolio
- 7.9.5 Vidalink Recent Developments
- 7.10 Sea Rainbow
- 7.10.1 Sea Rainbow Company Information
- 7.10.2 Sea Rainbow Business Overview
- 7.10.3 Sea Rainbow Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.10.4 Sea Rainbow Pharmacy Benefit Management (PBM) Product Portfolio
- 7.10.5 Sea Rainbow Recent Developments
- 7.11 Cachet
- 7.11.1 Cachet Company Information
- 7.11.2 Cachet Business Overview
- 7.11.3 Cachet Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 7.11.4 Cachet Pharmacy Benefit Management (PBM) Product Portfolio
- 7.11.5 Cachet Recent Developments
8 North America
- 8.1 North America Pharmacy Benefit Management (PBM) Revenue (2021-2032)
- 8.2 North America Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 8.2.1 North America Pharmacy Benefit Management (PBM) Revenue by Type (2021-2026)
- 8.2.2 North America Pharmacy Benefit Management (PBM) Revenue by Type (2027-2032)
- 8.3 North America Pharmacy Benefit Management (PBM) Revenue Share by Type (2021-2032)
- 8.4 North America Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 8.4.1 North America Pharmacy Benefit Management (PBM) Revenue by Application (2021-2026)
- 8.4.2 North America Pharmacy Benefit Management (PBM) Revenue by Application (2027-2032)
- 8.5 North America Pharmacy Benefit Management (PBM) Revenue Share by Application (2021-2032)
- 8.6 North America Pharmacy Benefit Management (PBM) Revenue by Country
- 8.6.1 North America Pharmacy Benefit Management (PBM) Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pharmacy Benefit Management (PBM) Revenue by Country (2021-2026)
- 8.6.3 North America Pharmacy Benefit Management (PBM) Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pharmacy Benefit Management (PBM) Revenue (2021-2032)
- 9.2 Europe Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 9.2.1 Europe Pharmacy Benefit Management (PBM) Revenue by Type (2021-2026)
- 9.2.2 Europe Pharmacy Benefit Management (PBM) Revenue by Type (2027-2032)
- 9.3 Europe Pharmacy Benefit Management (PBM) Revenue Share by Type (2021-2032)
- 9.4 Europe Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 9.4.1 Europe Pharmacy Benefit Management (PBM) Revenue by Application (2021-2026)
- 9.4.2 Europe Pharmacy Benefit Management (PBM) Revenue by Application (2027-2032)
- 9.5 Europe Pharmacy Benefit Management (PBM) Revenue Share by Application (2021-2032)
- 9.6 Europe Pharmacy Benefit Management (PBM) Revenue by Country
- 9.6.1 Europe Pharmacy Benefit Management (PBM) Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pharmacy Benefit Management (PBM) Revenue by Country (2021-2026)
- 9.6.3 Europe Pharmacy Benefit Management (PBM) Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pharmacy Benefit Management (PBM) Revenue (2021-2032)
- 10.2 China Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 10.2.1 China Pharmacy Benefit Management (PBM) Revenue by Type (2021-2026)
- 10.2.2 China Pharmacy Benefit Management (PBM) Revenue by Type (2027-2032)
- 10.3 China Pharmacy Benefit Management (PBM) Revenue Share by Type (2021-2032)
- 10.4 China Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 10.4.1 China Pharmacy Benefit Management (PBM) Revenue by Application (2021-2026)
- 10.4.2 China Pharmacy Benefit Management (PBM) Revenue by Application (2027-2032)
- 10.5 China Pharmacy Benefit Management (PBM) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharmacy Benefit Management (PBM) Revenue (2021-2032)
- 11.2 Asia Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 11.2.1 Asia Pharmacy Benefit Management (PBM) Revenue by Type (2021-2026)
- 11.2.2 Asia Pharmacy Benefit Management (PBM) Revenue by Type (2027-2032)
- 11.3 Asia Pharmacy Benefit Management (PBM) Revenue Share by Type (2021-2032)
- 11.4 Asia Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 11.4.1 Asia Pharmacy Benefit Management (PBM) Revenue by Application (2021-2026)
- 11.4.2 Asia Pharmacy Benefit Management (PBM) Revenue by Application (2027-2032)
- 11.5 Asia Pharmacy Benefit Management (PBM) Revenue Share by Application (2021-2032)
- 11.6 Asia Pharmacy Benefit Management (PBM) Revenue by Country
- 11.6.1 Asia Pharmacy Benefit Management (PBM) Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pharmacy Benefit Management (PBM) Revenue by Country (2021-2026)
- 11.6.3 Asia Pharmacy Benefit Management (PBM) Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharmacy Benefit Management (PBM) Revenue (2021-2032)
- 12.2 SAMEA Pharmacy Benefit Management (PBM) Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pharmacy Benefit Management (PBM) Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pharmacy Benefit Management (PBM) Revenue by Type (2027-2032)
- 12.3 SAMEA Pharmacy Benefit Management (PBM) Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pharmacy Benefit Management (PBM) Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pharmacy Benefit Management (PBM) Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pharmacy Benefit Management (PBM) Revenue by Application (2027-2032)
- 12.5 SAMEA Pharmacy Benefit Management (PBM) Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pharmacy Benefit Management (PBM) Revenue by Country
- 12.6.1 SAMEA Pharmacy Benefit Management (PBM) Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pharmacy Benefit Management (PBM) Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pharmacy Benefit Management (PBM) Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst